How to Run Clinical Trials in Private Practice
|
|
|
- Branden Hoover
- 10 years ago
- Views:
Transcription
1 How to Run Clinical Trials in Private Practice Thomas M. Siler, MD Midwest Chest Consultants, PC Saint Charles, MO
2 DISCLOSURE Dr. Siler has received research grants from GlaxoSmithKline, Forest, Boehringer Ingelheim, Sunovion, Novartis, Daiichi, Elevation and participates in Boehringer Ingelheim, Novartis, and UCB speakers bureau, but these do not create a conflict related to the following presentation.
3 Disclosures Research Support Pearl Therapeutics, Forest Research Institute, GSK, Novartis, Sunovion, Boehringer-Ingelheim, Daiichi-Sankyo Speakers Bureau UCB, Novartis, Boehringer-Ingelheim
4 Question 1 What is the best basketball program in the NCAA? 1. Duke 2. Kansas 3. Kentucky 4. Syracuse
5 What is the best basketball program in the NCAA? 1. Duke 2. Kansas 3. Kentucky 4. Syracuse 33% 25% 25% 17%
6
7
8 Midwest Chest Consultants, PC Practice located in St. Charles, MO in St. Louis Metro area 2 Physicians and 4 Nurse Practitioners 5 full time research staff 1 pharmacist, 1 RN, 1 medical assistant and 2 BA All staff are certified by ACRP (CCRC) Research staff is devoted to research only
9 Midwest Chest Consultants, PC First clinical trial done in 1994 Have been involved in over 125 trials Last year had 193 subjects and 14 active trials Primarily COPD trials, have also done anticoagulation trials Have done Phase 2, 3 and 4 trials Initially did some inpatient trials, now only outpatient
10 Midwest Chest Consultants, PC Initially started with one NP working part time on one trial Quickly discovered that part time staff does not work well difficult to keep up with all of the paperwork and scheduling required Moved quickly to hiring full time staff dedicated to research Research moved to separate area
11 Question 2 Do you do clinical trials? A. Yes, in private practice B. Yes, in academic practice C. No, but have in past D. No, have never done trials
12 Do you do clinical trials? A. Yes, in private practice B. Yes, in academic practice C. No, but have in past D. No, have never done trials 18% 33% 25% 25% A. B. C. D.
13 Factors to Consider 75% of investigators do one trial Need line of credit or other financial resources Payment often occurs 3-6 months after services are performed Need capital to pay staff and research subjects Once site is up and running can make significant revenue if carefully managed Physician needs time to be involved in supervising trials FDA requires oversight
14 Staff Dedicated staff that do not have non-research duties is ideal Background of my staff is broad I have 1 pharmacist, 1 RN, 1 medical assistant and 2 staff with college degrees Finding staff with previous research experience is helpful especially when starting All staff is required to have GCP and human subject protection training including sub-investigators
15 Staff Clinical research coordinators are basic staff to collect research data My site has a director of research who negotiates contracts, does regulatory documents and manages staff Larger sites often have dedicated recruiters one of my coordinators does recruiting half-time
16 Staff Certification All of my staff are Certified Clinical Research Coordinators (CCRC) offered by ACRP Requires 3,000 hours of experience with college degree or RN, 4,500 hours without Must pass written exam on GCP, CFR and conduct of clinical trials Must have 24 research contact hours every 2 years Certification also offered by SOCRA (CCRP)
17 Staff Training Each staff member attends a national research meeting at least every 2 years Staff also receives training on each protocol at investigator meetings As we do COPD trials, all staff has had extensive training in spirometry and lung volume testing. I have a full-time RPFT on my clinical staff to provide support
18 Facilities Our site is physically separate from the clinical practice and is located across the hall We have 6 exam/procedure rooms For COPD trials, some of which require 14 hour visits, a lounge area for subjects is essential Each coordinator also has a desk with computer to do paperwork and data entry
19 Facilities Need secure storage for investigational products (IP) Storage for records also needed. Although most sponsors are using electronic case reports forms, many source documents are still on paper Need space for study monitors to review records
20 Facilities Need refrigeration for some IP s which also needs to be locked Trials doing pharmacokinetics often require samples to be stored a -70 C until shipped. We use a space in the hospital lab for this High speed wireless Internet access for monitors and transmitting data essential Analog phone lines also needed for modem transmission of data
21 Question 3 Which of the following are important factors in running a clinical trials practice? 1. Staff dedicated to clinical research that do not have other practice responsibilities. 2. Separate space. 3. Principal investigator involvement. 4. All of the above.
22 Which of the following are important factors in running a clinical trials practice? 100% 1. Staff dedicated to clinical research that do not have other practice responsibilities. 2. Separate space. 3. Principal investigator involvement. 4. All of the above. 0% 0% 0%
23 Study Contracts Legal review of contracts recommended Sponsors write contracts that favor them Indemnification sections need to be carefully reviewed to insure adequate protection Contracts are usually made either directly with sponsors or with Contract Research Organizations (CRO) With CRO contracts must insure protection in the event of CRO problems that payment to site is not effected
24 Site Management Organizations SMO s provide access to contracts for a fee Fee is often based on contracted number of subjects so if a site under enrolls a study, fee can be a large part of the total reimbursement I have never used an SMO I think it s better to leave out the middleman and work directly with sponsors and CRO s
25 Study Contracts Number of subjects Most sponsors want sites to commit to a certain number of subjects Be very careful to be realistic if you commit to 10 subjects and enroll 3, a sponsor may not want to work with you again. It s better to be conservative and then go back and ask to over enroll if you have reached your contracted number
26 Study Contracts Don t be afraid to refuse studies that your site cannot meet enrollment or is outside of the expertise of your site. Sponsors respect sites that know their capabilities Sponsors indicate many sites just sign contracts and never ask any questions or request revisions
27 Budgets Probably the most important factor in financial success of a site Sponsors often low ball budgets and usually sites can negotiate higher payment We always ask for non-refundable study start up payment Covers the cost of doing regulatory documentation, IRB communications and contract and budget review
28 Budgets Review each visit in protocol We prepare a spreadsheet with each study procedure informed consent, medical history, exams, vital signs, EKG s, spirometry, blood draws, questionnaire administration and any other procedures in protocol We have a standard charge for each procedure in spreadsheet We also ask for money for query resolution, record storage and SAE reporting.
29 Budgets Once analysis is done, it is much easier to go back to a sponsor or CRO and tell them that your analysis shows that the budget is too low If a sponsor will not increase the budget to a reasonable amount, we walk away If you don t get adequate compensation you put your practice at financial risk We find that often, when they realize we are serious, they will come back with a better offer
30 Payments Be careful in reviewing payment milestones Sponsors will often set payments based on monitoring milestones Better to have payment based on visit completion and computer data entry by site, not monitor Try and get payments made monthly or based on visits completed Sponsors will often pay quarterly which may mean payments will be made 4-6 months after work done which can cause cash flow problems
31 Payments Must keep track of payments owed Hold sponsors and CRO s to contracted payment schedules We have been forced to threaten to stop enrollment and in one case, threatened to stop patient visits in order to force payment
32 Institutional Review Boards Advantage of being in private practice for sponsors is the ability to use a Central IRB rather than a local IRB for protocol approval This can significantly decrease start up time Also makes reporting easier for site as the sponsor can transmit reports for multiple sites Site is still responsible to submit information concerning subject safety directly to IRB
33 Recruiting Recruit from practice We get about half of our subjects from our practice Important to have all providers remember to offer research opportunities to appropriate subjects Advertising We always try to get advertising money from sponsors in our contracts We have used direct mailing, radio and TV Some sponsors use national advertising
34 Recruiting Screening subjects We pre-screen all subjects after they sign a generic screening consent form with spirometry and a medical history review This avoids finding out a subject s FEV1 is not appropriate for a study after reviewing a 25 page consent form with them This also reduces our screen fail rate for studies which is important to sponsors
35 FDA Requirements Code of Federal Regulations Title 21 (CFR 21) contains the federal law governing the FDA s oversight responsibilities for clinical trials International Conference on Harmonization (ICH) provides guidance for Good Clinical Practice (GCP) ICH-E6 is current guidance Guidance has origins with Declaration of Helsinki
36 FDA Requirements Form 1572 outlines requirements of principal investigator (PI) PI is responsible for all activities at site Procedures can be delegated to study staff members based on their credentials but PI is ultimately accountable FDA may inspect sites to insure compliance Our site has had one audit
37 FDA Requirements Audits 3 findings No action indicated (NAI), voluntary action indicated (VAI) or official action indicated (OAI) VAI requires a response OAI can result in civil and/or criminal penalties Our audit had VAI findings
38 Common FDA Audit Findings Failure to follow protocol Inadequate records Drug accountability Informed consent deficiencies IRB Communication Adverse event reporting
39 Question 4 Who is responsible for conduct of a trial at a clinical site? 1. Sponsor 2. CRO 3. Principal Investigator 4. FDA
40 Who is responsible for conduct of a trial at a clinical site? 1. Sponsor 2. CRO 3. Principal Investigator 4. FDA 98% 2% 0% 0%
41
42
The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial
The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial Clinical Research Operations & Regulatory Support (CRORS) Ann Glasse, RN, BSN, MBA Director-CRORS Objectives
To Certify or Not to Certify
To Certify or Not to Certify Sandra Halvorson, BA, CCRP Clinical Research Coordinator II CIBMTR Minneapolis Campus Sue Logan, BS, CCRP Clinical Research Coordinator II CIBMTR Minneapolis Campus November
To Certify or Not to Certify Sandra Halvorson, BA, CCRP
To Certify or Not to Certify Sandra Halvorson, BA, CCRP Clinical Research Coordinator II CIBMTR Minneapolis Campus Sue Logan, BS, CCRP Clinical Research Coordinator II We have no financial relationships
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:
Good Clinical Practice 101: An Introduction
Good Clinical Practice 101: An Introduction Presented by: Lester Jao Lacorte, MD Medical Officer Commissioner s Fellow Division of Bioresearch Monitoring Office of Compliance Center for Devices and Radiological
Good Documentation Practices
Good Documentation Practices Clinical Research Operations & Regulatory Support Ann Glasse, RN, BSN, MBA Director, Regulatory Support Author: Johanna Stamates, RN, MA, CCRC, CHRC Objectives Recognize the
NEGOTIATING CLINICAL TRIAL BUDGETS. Debbie Williams R.N., C.C.R.C., C.R.A., A.B.N.
NEGOTIATING CLINICAL TRIAL BUDGETS Debbie Williams R.N., C.C.R.C., C.R.A., A.B.N. A.B.N. Amateur Budget Negotiator OVERVIEW Budget Types Analyzing the Protocol Negotiating the Contract Discussion / Tips
Essential Documents for the Conduct of a Clinical Trial. Debra Dykhuis Associate Director RSO
Essential Documents for the Conduct of a Clinical Trial Debra Dykhuis Associate Director RSO Introduction Rationale for choosing this topic AHC movement toward setting GCP (Good Clinical Practice) guidelines
Information Sheet Guidance for Sponsors, Clinical Investigators, and IRBs
Information Sheet Guidance for Sponsors, Clinical Investigators, and IRBs Frequently Asked Questions Statement of Investigator (Form FDA 1572) U.S. Department of Health and Human Services Food and Drug
ROLE OF THE RESEARCH COORDINATOR Study Start-up Best Practices
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators ROLE OF THE RESEARCH COORDINATOR Study Start-up
PREP Workshop #31: Preparing for Certification as a Clinical Research Coordinator
PREP Workshop #31: Preparing for Certification as a Clinical Research Coordinator Presented by: Susan Ray, MS, CCRC Supervisor Research Coordination Clinical Research Service CME Disclosure Statement The
Cheryl K. Bernstein RN, BSN, CCRC Director Bernstein Clinical Research Center, LLC Cincinnati, Ohio [email protected]
Cheryl K. Bernstein RN, BSN, CCRC Director Bernstein Clinical Research Center, LLC Cincinnati, Ohio [email protected] Identify and discuss the language used in reciprocal or crossed indemnification and
Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / Pharmaceutical Industry
Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / Pharmaceutical Industry By http://www.clinicalresearchassociate cra.com/studyguide/ A clinical research associate (CRA) is a
GOOD CLINICAL PRACTICE: CONSOLIDATED GUIDELINE
ICH E6 GCP: Consolidated Guideline: Investigator 1/7 Institutional Review Board Services ICH HARMONIZED TRIPARTITE GUIDELINE E6: GOOD CLINICAL PRACTICE: CONSOLIDATED GUIDELINE 4. INVESTIGATOR 4.1 Investigator's
Clinical Research Professional Certification & Preparing for the CCRP Exam
Clinical Research Professional Certification & Preparing for the CCRP Exam Signe Denmark, MS, CCRP Toni Mauney, CCRP SoCRA: Society of Clinical Research Associates SoCRA established the Certification Program
Investigational Drugs: Investigational Drugs and Biologics
: I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place
ICH CRA Certification Guide March 2009
ICH CRA Certification Guide March 2009 ICH CRA CERTIFICATION GUIDE... 1 GENERAL INFORMATION... 2 BENEFITS OF CERTIFICATION... 2 INDUSTRY RECOGNITION... 2 ABOUT THE EXAM... 2 CRA DEFINITION... 2 REQUIREMENTS
Principal Investigator and Sub Investigator Responsibilities
Principal Investigator and Sub Investigator Responsibilities I. Purpose To define the roles and responsibilities of Principal Investigators conducting research at GRU. II. Definition The term Principal
Comprehensive Study Documents List (Biomedical Studies)
Comprehensive Study Documents List (Biomedical Studies) Investigators conducting human subjects research must maintain study documents in adherence to federal and state regulations, USC policies, and good
The Beginner Research Assistant/Coordinator (CRC) Track Basic Level
The Beginner Research Assistant/Coordinator (CRC) Track Basic Level Who: Clinical Research Assistant (CRA) CRC I This track was designed for the CRA/CRC I with less than 2 years of clinical research experience.
The Monitoring Visit. Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis
The Monitoring Visit Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis Disclosure The information herein is not intended to
Clinical Investigator Inspections and FDA-483 Observations
Clinical Investigator Inspections and FDA-483 Observations Nancy A. Bellamy, Investigator Bioresearch Specialist/ BIMO Coordinator FDA Detroit District Office October 2, 2013 Objectives Background on FDA
CNE Disclosures. To change this title, go to Notes Master
CNE Disclosures Successful Completion: Participants must complete an evaluation form to receive a certificate of completion Contact Hours: 1 contact hour is available to those who meet the successful completion
FDA Presentation - Society for Clinical Research Sites
FDA Presentation - Society for Clinical Research Sites FDA Presentation - Dr. Richard Moscicki, MD FDA CDER Deputy Director for Clinical Research Sites Faculty Disclosure In compliance with ACCME Guidelines,
AAHRPP DOCUMENT # 84 UNIVERSITY OF ALABAMA HUMAN RESEARCH PROTECTIONS PROGRAM FORM: NOTIFICATION TO IRB OF EMERGENCY USE OF A TEST ARTICLE
1 AAHRPP DOCUMENT # 84 UNIVERSITY OF ALABAMA HUMAN RESEARCH PROTECTIONS PROGRAM FORM: NOTIFICATION TO IRB OF EMERGENCY USE OF A TEST ARTICLE Instructions Test Article means any drug, biological product,
Application for Research
Application for Research All research conducted within the Brooks Rehabilitation system or any entity or facility bearing the Brooks name, including the Brooks Rehabilitation Clinical Research Center,
CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE]
CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE] CONTRACT RESEARCH ORGANIZATION SPONSOR [NAME] [ADDRESS] 1 TABLE OF CONTENTS 1. Purpose 3 2. References 3 3. Study Roles and Responsibilities
Clinical Investigator Training Course
Clinical Investigator Training Course Investigator Responsibilities in Biomedical Research Covered by FDA Regulations Lisa Zimmerman Objectives Discuss Clinical Investigator Obligations according to FDA
Differential Training by Job Function ACRP Job Analysis Results
Differential Training by Job Function ACRP Job Analysis Results Morgean Hirt, ACA, Director of Certification Association of Clinical Research Professionals Disclaimer The views and opinions expressed in
Pre-Questions. Mastering Clinical Research July 29, 2015
Pre-Questions Mastering Clinical Research July 29, 2015 1. To be compliant with SOP 2.1 Obtaining Informed Consent for greater than minimal risk interventional clinical trial, which Licensed Professional
PREP Course #27: Medical Device Clinical Trial Management
PREP Course #27: Medical Device Clinical Trial Management Presented by: Evelyn Huang Jeffrey Revello Office of Research Compliance North Shore-LIJ Health System CME Disclosure Statement The North Shore
Study Start-Up SS-204.01. STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV)
Study Start-Up SS-204.01 STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV) Approval: Nancy Paris, MS, FACHE President and CEO 08 March 2012 (Signature and Date) Approval: Frederick M. Schnell,
HIPAA Privacy & Security Training for Clinicians
HIPAA Privacy & Security Training for Clinicians Agenda This training will cover the following information: Overview of Privacy Rule and Security Rules Using and disclosing Protected Health Information
This unit will provide the structure needed to achieve successful supervision and oversight of the study. We will explain the importance of an
Music No audio Please review information shown to understand the general course navigation and available resources. Resources, such as the audio script, example forms, and website links, can be accessed
Guidance for Industry Investigator Responsibilities Protecting the Rights, Safety, and Welfare of Study Subjects
Guidance for Industry Investigator Responsibilities Protecting the Rights, Safety, and Welfare of Study Subjects U.S. Department of Health and Human Services Food and Drug Administration Center for Drug
Engaging Clinical Trial Sites:
WHITE PAPER Engaging Clinical Trial Sites: The Role of the Clinical Trial Liaison Author: MARTIN LEE, MD Vice President, Global Scientific Affairs PRA Health Sciences Key Customers in Clinical Research
The Study Site Master File and Essential Documents
The Study Site Master File and Essential Documents Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 002 Version number: 1 Effective date: 01 June 2010
Electronic Medical Records and Source Data for Research: What s the Difference?
Electronic Medical Records and Source Data for Research: What s the Difference? Tammy Anderson, CCRC, CCRA, CRCP Director, Clinical Trials Office Virginia Commonwealth University Research Coordinator 4
12.0 Investigator Responsibilities
v. 5.13.13 12.0 Investigator Responsibilities 12.1 Policy Investigators are ultimately responsible for the conduct of research. Research must be conducted according to the signed Investigator statement,
Achieving High Quality Clinical Research Seminar Series. March 19, 2014. Rebecca Gavitt, BSN, RN, CCRA Sue Parsons Nicolás Samper, MS CCRA
Achieving High Quality Clinical Research Seminar Series March 19, 2014 Rebecca Gavitt, BSN, RN, CCRA Sue Parsons Nicolás Samper, MS CCRA Introduction Agenda Definition of a CRA What types of visits are
and Regulatory Aspects
Good Clinical Practice and Regulatory Aspects Nora Espiritu MD, MPh, PhD (c) Former Executive Director of Research and Technology Transfer. Peruvian National Institute t of Health. Member of the Ethics
Objectives. Monitoring & Auditing of Clinical Trials. Overview. Pre-study Qualification Visit. Industry-sponsored Trials
Objectives Monitoring & Auditing of Clinical Trials Sponsored by Center for Cancer Research National Cancer Institute Guidelines suggest that following the good clinical research practice of monitoring/auditing
Quality Monitoring Checklist
Quality Monitoring Checklist Instructions: For each task below, the Quality Monitor indicates in the appropriate column if the Monitor accomplished the task by using the following codes Yes No N/A = Monitor
Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health
Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health We are responsible for acquiring, analyzing, and protecting medical information vital to providing quality patient care HIM professionals ensure
Guidance for Industry. IRB Review of Stand-Alone HIPAA Authorizations Under FDA Regulations
Guidance for Industry IRB Review of Stand-Alone HIPAA Authorizations Under FDA Regulations FINAL This guidance is being distributed GUIDANCE for immediate implementation. FDA is issuing this guidance for
Fundamentals of Clinical Trial Financial Management
Fundamentals of Clinical Trial Financial Management Lindsey Spangler Michelle Smith COURSE OBJECTIVES Understand the life cycle of a clinical study from a financial perspective Understand the purpose of
Ethics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong. Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015
Ethics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015 Clinical Trials at HKU Phase 1 Phase II Phase III Phase IV Conducted on patient
Medical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11
Effective Date: 09/12/06, 08/02/10, 3/2/11 Title: 1.0 OBJECTIVE: 1.1 This SOP describes the methods and policies for: Handling investigational drug Dispensing investigational drug 1.2. This procedure applies
No. 706. Page 1 of 5. Issue Date 4/21/2014
Subject: ROUTINE MONITORING VISITS Standard Operating Procedure Prepared By: Beaumont Research Coordinating Center, Research Institute PURPOSE Prior Issue Date 8/15/2011 No. 706 Issue Date 4/21/2014 Page
How to Develop a Clinical Study Site Budget
How to Develop a Clinical Study Site Budget Mary Fautsch Dale Klous White Paper 6/23/2011 Abstract Summary In today s dynamic environment, there is a need like never before for clinical data. In addition
Signature Requirements for the etmf
Wingspan Technology Signature Requirements for the etmf A Regulatory and Technological Assessment Kathie Clark Director, Product Management Wingspan Technology 1 November 2012 Signature Requirements for
The Importance of Following the PROTOCOL in Clinical Trials
The Importance of Following the PROTOCOL in Clinical Trials Presentation Objectives: Upon completion of this presentation, participants will be able to: Describe the following terms: Protocol, Protocol
Investigator responsibilities for research conducted under the authority of the UTHSCSA Institutional Review Board (IRB)
March 1, 2006 M E M O R A N D U M F O R R E C O R D TO: FROM: SUBJECT: Deans Department Chairs Principal Investigators Brian Herman, Ph.D. Vice President for Research Investigator responsibilities for
Essential Documents for Clinical Trial Research. Centre for Health Evaluation and Outcome Sciences Manager, Clinical Research Development Office
Essential Documents for Clinical Trial Research Erin Cherban, MSc., CCRP Centre for Health Evaluation and Outcome Sciences Manager, Clinical Research Development Office Document Examples See the following
Moving from Compliance to Competency for the Clinical Research Professional
Click to Edit Master Title Style Moving from Compliance to Competency for the Clinical Research Professional Rebecca Li, PhD, Executive Director Building A Learning Community Among Key Stakeholders - 1
Keys to Building a Successful Research Site. Duke Clinical Research Institute UNDERSTANDING THE REGULATORY ENVIRONMENT
Keys to Building a Successful Research Site UNDERSTANDING THE REGULATORY ENVIRONMENT MEETING PRINCIPAL INVESTIGATOR OBLIGATIONS TRAINING YOUR STUDY COORDINATOR RECRUITING AND RETAINING SUBJECTS MANAGING
Roles & Responsibilities of the Sponsor
Roles & Responsibilities of the Sponsor Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Funding for clinical research comes from
Health Care Job Information Sheet #20. Clinical Research
Health Care Job Information Sheet #20 Clinical Research A. Background B. Occupations 1) Clinical Research Associate (Study Monitor) 2) Clinical Research Coordinator 3) Other positions in the field C. Labour
Monitoring & Auditing of Clinical Trials. Sponsored by Center for Cancer Research National Cancer Institute
Monitoring & Auditing of Clinical Trials Sponsored by Center for Cancer Research National Cancer Institute Objectives Guidelines suggest that following the good clinical research practice of monitoring/auditing
2.2 Roles and Responsibilities in the Conduct and Assessment of Clinical Trials
L1 2.2 Roles and Responsibilities in the Conduct and Assessment of Clinical Trials Presentation to APEC Preliminary Workshop on Review of Drug Development in Clinical Trials Celia Lourenco, PhD, Manager,
IMP management at site. Dmitry Semenyuta
IMP management at site Dmitry Semenyuta TOP 5 FDA inspections finding 1999-2009 Center of Drug Evaluation and Research (CDER) Failure to follow the protocol Failure to keep adequate and accurate records
Objectives. The Paper Tells the Story
Notes to File: An Auditor s Perspective Lorrie D. Divers, CCRP, RQAP-GCP Executive Director, Global Quality Assurance & Compliance ACM Medical Laboratory / ACM Global Central Laboratory Clinical Translation
Guidance on Withdrawal of Subjects from Research: Data Retention and Other Related Issues
Office for Human Research Protections (OHRP) Department of Health and Human Services (HHS) Guidance on Withdrawal of Subjects from Research: Data Retention and Other Related Issues This guidance represents
Harmonized Core Competencies in Clinical Research: evolutions and next steps for meeting the challenge
Harmonized Core Competencies in Clinical Research: evolutions and next steps for meeting the challenge Master of Applied Clinical and Preclinical Research macpr.osu.edu Consortium of Academic Programs
Patient Information Form Trinity Wellness Center. Insurance Information
Patient Information Form Trinity Wellness Center Last Name, First Name, MI* Date of Birth* / / Social Security # -- -- Sex* : Female / Male Student Status (circle one): Full-time / Part-time / not a student
Role of IRB/IEC in GCP. Benjamin Kuo, MD, Dr.PH, CIP.
Role of IRB/IEC in GCP Benjamin Kuo, MD, Dr.PH, CIP. Institutional Review Board (IRB) An independent body constituted of medical, scientific and non scientific members Responsible for ensuring protection
LUNG CANCER CLINICAL TRIALS
UNDERSTANDING LUNG CANCER CLINICAL TRIALS 1-800-298-2436 LungCancerAlliance.org A GUIDE FOR THE PATIENT 1 TABLE OF CONTENTS INTRODUCTION TO CLINICAL TRIALS What Is a Clinical Trial?...4 Types of Clinical
The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations
The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations Maria Luisa Paoloni OPBG Clinical & Research Services Monitoring and Responsible of monitoring:
Version history Version number Version date Effective date 01 dd-mon-yyyy dd-mon-yyyy 02 dd-mon-yyyy dd-mon-yyyy 03 (current) dd-mon-yyyy dd-mon-yyyy
Trial name: HOVON xxx yyy Sponsor: HOVON Version history Version number Version date Effective date 01 dd-mon-yyyy dd-mon-yyyy 02 dd-mon-yyyy dd-mon-yyyy 03 (current) dd-mon-yyyy dd-mon-yyyy QRMP authors
Guidance to Research Ethics Committees on Initial Facility Assessment
Guidance to Research Ethics Committees on Initial Facility Assessment Introduction One of the roles of a Research Ethics Committee is to provide an opinion on a proposed study, based on the suitability
Building the Foundation for Clinical Research Nursing
National Institutes of Health Clinical Center Nursing and Patient Care Services Building the Foundation for Clinical Research Nursing DOMAIN OF PRACTICE FOR THE SPECIALTY OF CLINICAL RESEARCH NURSING 9/4/2009
INTERIM SITE MONITORING PROCEDURE
INTERIM SITE MONITORING PROCEDURE 1. PURPOSE The purpose of this SOP is to describe the interim monitoring procedures conducted at Institution, according to GCP and other applicable local regulations.
History and Principles of Good Clinical Practice
History and Principles of Good Clinical Practice Cristina E. Torres, Ph.D. Social Science Professor, UPM-NIH FERCAP Coordinator ICH: International Conference on Harmonization GCP: Good Clinical Practices
Catherine Jahrsdorfer, RN, BSN Director of Clinical Services USF Health Office of Clinical Research
A Practical Guide on Applying USF HRPP P&Ps in the Clinical Setting Catherine Jahrsdorfer, RN, BSN Director of Clinical Services USF Health Office of Clinical Research Learning Objectives Recognize the
Subject: No. Page PROTOCOL AND CASE REPORT FORM DEVELOPMENT AND REVIEW Standard Operating Procedure
703 1 of 11 POLICY The Beaumont Research Coordinating Center (BRCC) will provide advice to clinical trial investigators on protocol development, content and format. Upon request, the BRCC will review a
Friday, May 2. Clinical Trials: Is Your Staff Competent? Session 10:15 11:45 am Ballroom C
Session 10:15 11:45 am Ballroom C Clinical Trials: Is Your Staff Competent? What fundamental skills and knowledge should clinical trials nurses have? In response to questions from its members about how
Human Research Protection Program Good Clinical Practice Guidance for Investigators Investigator & Research Staff Responsibilities
This Guidance Document is to ensure that investigators and research personnel recognize their responsibilities associated with the conduct of human subject research by outlining their responsibilities,
LI, Huafang MD., Ph.D. Shanghai Mental Health Center Shanghai Jiao Tong University School of Medicine, Shanghai, China
Late Clinical Trials in China LI, Huafang MD., Ph.D. Shanghai Mental Health Center Shanghai Jiao Tong University School of Medicine, Shanghai, China Biography Huafang LI, M.D., Ph.D., Chief-Psychiatrist,
Orientation Manual for Clinical Research Coordinators
Orientation Manual for Clinical Research Coordinators Maine Medical Center Research Institute Page 1 of 19 Version 1 (2009) MAINE MEDICAL CENTER RESEARCH INSTITUTE Statement of Mission, Vision, Goals and
Investigator Responsibilities Regulation and Clinical Trials
Investigator Responsibilities Regulation and Clinical Trials FDA S 2013 Clinical Investigator Training Course Cynthia F. Kleppinger, M.D. Division of Good Clinical Practice Compliance Office of Scientific
A Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky
A Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky I. Compliance with IRB and Applicable Federal Requirements A. Investigators
CONDUCTING GLOBAL CLINICAL RESEARCH TRIALS:
CONDUCTING GLOBAL CLINICAL RESEARCH TRIALS: COMPARING AND CONTRASTING FDA MEDICAL DEVICE REGULATIONS FOR CLINICAL INVESTIGATORS WITH ISO 14155:2011 Introduction Today s clinical research landscape for
Understanding Clinical Trial Recruitment Rules
Understanding Clinical Trial Recruitment Rules Richard Klein Patient Liaison Program Director Office of Health and Constituent Affairs Food and Drug Administration CTTI Patient Group and Clinical Trials
HIPAA Notice of Privacy Practices
HIPAA Notice of Privacy Practices THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY. This Notice
CLINICAL RESEARCH ROLES CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES
CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES 1. Clinical Study Team Principal Investigator Co Principal Investigator (Co PI) Research Coordinator Study Monitor Data manage Sponsor Post Doctoral Scholar
Guide for Research Sites Seeking Accreditation
Guide for Research Sites Seeking Accreditation (For research sites that only conduct research and do not have their own IRBs) November 16, 2010 Purpose of the Guide The accreditation process for most research
Data Management & Case Report Form Development in Clinical Trials. Introduction to the Principles and Practice of Clinical Research.
Data Management & Case Report Form Development in Clinical Trials Introduction to the Principles and Practice of Clinical Research February 3, 2015 Marge Good, RN, MPH, OCN Nurse Consultant Division of
To know more about Pharmacovigilance and Clinical Trials Data Management
To know more about Pharmacovigilance and Clinical Trials Data Management 1. What is Pharmacovigilance? Pharmacovigilance (PV) is the pharmacological science related to the detection, assessment, understanding
Practical aspects of early phase oncology trials the oncologists view
Practical aspects of early phase oncology trials the oncologists view S. E. Al-Batran, MD Head, Institute of Clinical Cancer Research (IKF) University Cancer Center (UCT) Nordwest Hospital Frankfurt Outline
WARNING LETTER. J'A randomized comparison of Jversusl. _. J in patients undergoing early invasive management forl ] performed for C.
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville, MD 20857 WARNING LETTER CERTIFIED MAIL RETURN RECEIPT REOUESTED Edward Mostel, M.D. Palm Beach Gardens
ROLE OF THE RESEARCH COORDINATOR
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators ROLE OF THE RESEARCH COORDINATOR Data Collection
Clinical Trials Budgeting and Billing
Clinical Trials Budgeting and Billing Presented by: Ellen N. Jamieson, MS, MBA Director, Grants Administration Alexandria Hui, BA Manager, Clinical Trial Financial Analyst Rules and Regulations Medicare
Policy on Human Subject Protection Training, Certification and Recertification at AUB
Policy on Human Subject Protection Training, Certification and Recertification at AUB Policy Number: 005 Draft Version Number: 1 Dated: Prepared and Edited by: Mona Nabulsi and Mary Ellen Sheridan (Consultant)
